Merck & Co Inc (NYSE:MRK)

105.02
BATS BZX Real-Time Price
As of 11:38am ET
 -0.51 / -0.48%
Today’s Change
80.74
Today|||52-Week Range
115.49
-5.34%
Year-to-Date
Moderna's CEO Just Gave Investors a Huge Reason to Sell the Stock
8:20am / MotleyFool.com - Paid Partner Content
Merck (MRK) Stock Sinks As Market Gains: What You Should Know
Mar 21 / Zacks.com - Paid Partner Content
Merck (MRK) Dips More Than Broader Markets: What You Should Know
Mar 28 / Zacks.com - Paid Partner Content
Top Research Reports for Merck, Intel & MercadoLibre
Mar 21 / Zacks.com - Paid Partner Content
GSK's Jemperli Effective Against First-Line Endometrial Cancer
Mar 28 / Zacks.com - Paid Partner Content
Is the Best-Performing Dow Stock of the Past Year a Buy?
Mar 21 / MotleyFool.com - Paid Partner Content
Should Invesco Dynamic Large Cap Value ETF (PWV) Be on Your Investing Radar?
Mar 28 / Zacks.com - Paid Partner Content
Merck (MRK) Stock Up 31.6% in a Year: What Awaits in 2023?
Mar 20 / Zacks.com - Paid Partner Content
Iovance (IOVA) Completes Rolling BLA Filing for Melanoma Drug
Mar 27 / Zacks.com - Paid Partner Content
Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?
Mar 20 / Zacks.com - Paid Partner Content
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Mar 27 / Zacks.com - Paid Partner Content
Is Invesco Dynamic Large Cap Value ETF (PWV) a Strong ETF Right Now?
Mar 20 / Zacks.com - Paid Partner Content
Is Nuveen ESG Large-Cap Value ETF (NULV) a Strong ETF Right Now?
Mar 27 / Zacks.com - Paid Partner Content
Could This Be Merck's Next Blockbuster Drug?
Mar 18 / MotleyFool.com - Paid Partner Content
3 Simple Ways to Supercharge Your Biopharma Investing Using Artificial Intelligence
Mar 24 / MotleyFool.com - Paid Partner Content
Merck's (MRK) Co-formulation Therapy Fails Lung Cancer Study
Mar 17 / Zacks.com - Paid Partner Content
Sanofi (SNY) Moves 6.0% Higher: Will This Strength Last?
Mar 24 / Zacks.com - Paid Partner Content
Pfizer's (PFE) COVID-19 Drug Paxlovid Gets FDA Panel Vote
Mar 17 / Zacks.com - Paid Partner Content
Here's Why You Should Add Novo (NVO) Stock to Your Portfolio
Mar 22 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: M&A Boom in Drug Industry With PFE & SNY Deals, Other Updates
Mar 17 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights Merck, Intel, MercadoLibre, The Travelers Companies and Halliburton
Mar 22 / Zacks.com - Paid Partner Content
This High-Growth Company Is Expanding. Time to Buy the Stock?
Mar 16 / MotleyFool.com - Paid Partner Content